These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35743189)

  • 61. Chlamydial and gonococcal cervicitis in HIV-seropositive and HIV-seronegative pregnant women in Bangkok: prevalence, risk factors, and relation to perinatal HIV transmission.
    Chaisilwattana P; Chuachoowong R; Siriwasin W; Bhadrakom C; Mangclaviraj Y; Young NL; Chearskul S; Chotpitayasunondh T; Mastro TD; Shaffer N
    Sex Transm Dis; 1997 Oct; 24(9):495-502. PubMed ID: 9339966
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epidemiologic characteristics of sexually transmitted infection/coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae.
    Cerkez-Habek J; Habek D
    Acta Med Croatica; 2001; 55(4-5):191-201. PubMed ID: 12398023
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Activities of first-choice antimicrobials against gamma interferon-treated Chlamydia trachomatis differ in hypoxia.
    Shima K; Klinger M; Solbach W; Rupp J
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2828-30. PubMed ID: 23478971
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of antibiotic treatment on active trachoma and ocular Chlamydia trachomatis infection.
    Mabey D; Solomon A
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):209-16. PubMed ID: 15482115
    [TBL] [Abstract][Full Text] [Related]  

  • 65.
    Rajabpour M; Emamie AD; Pourmand MR; Goodarzi NN; Asbagh FA; Whiley DM
    Int J STD AIDS; 2020 Jul; 31(8):773-780. PubMed ID: 32517577
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.
    Kimura M; Kishimoto T; Niki Y; Soejima R
    Antimicrob Agents Chemother; 1993 Apr; 37(4):801-3. PubMed ID: 8494377
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model.
    Kutlin A; Roblin PM; Hammerschlag MR
    J Antimicrob Chemother; 2002 May; 49(5):763-7. PubMed ID: 12003969
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preventing infective sequelae of abortion.
    Penney GC
    Hum Reprod; 1997 Nov; 12(11 Suppl):107-12. PubMed ID: 9433966
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of difloxacin in the treatment of uncomplicated urethral gonorrhea in men.
    Smith BL; Cummings M; Benes S; Draft K; McCormack WM
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1721-3. PubMed ID: 2511799
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Chlamydia infections in gynecology and obstetrics].
    Dieterle S
    Geburtshilfe Frauenheilkd; 1995 Sep; 55(9):510-7. PubMed ID: 7498719
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection.
    McCormack WM; Martin DH; Hook EW; Jones RB
    Infect Dis Obstet Gynecol; 1998; 6(3):109-15. PubMed ID: 9785106
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro activity of temafloxacin against pathogens causing sexually transmitted diseases.
    Segreti J
    Am J Med; 1991 Dec; 91(6A):24S-26S. PubMed ID: 1662891
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chlamydia trachomatis--clinical significance and strategies of intervention.
    Weström LV
    Semin Dermatol; 1990 Jun; 9(2):117-25. PubMed ID: 2202407
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study.
    Ota KV; Fisman DN; Tamari IE; Smieja M; Ng LK; Jones KE; Diprima A; Richardson SE
    Clin Infect Dis; 2009 May; 48(9):1237-43. PubMed ID: 19323630
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones.
    Ryan L; Daly P; Cullen I; Doyle M
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1001-1008. PubMed ID: 29450767
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Time to clearance of Chlamydia trachomatis RNA and DNA after treatment in patients coinfected with Neisseria gonorrhoeae - a prospective cohort study.
    Wind CM; Schim van der Loeff MF; Unemo M; Schuurman R; van Dam AP; de Vries HJ
    BMC Infect Dis; 2016 Oct; 16(1):554. PubMed ID: 27724878
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence of Chlamydia trachomatis, Trichomonas vaginalis and Neisseria gonorrhoeae Based on Data Collected by a Network of Clinical Microbiology Laboratories, in Italy.
    Salfa MC; Suligoi B;
    Adv Exp Med Biol; 2016; 901():47-57. PubMed ID: 26691509
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.
    Bowie WR; Shaw CE; Chan DG; Boyd J; Black WA
    Antimicrob Agents Chemother; 1986 Oct; 30(4):590-3. PubMed ID: 3098163
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of uncomplicated infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae.
    Klepser ME; Quintiliani R; Nightingale CH
    Conn Med; 1994 Aug; 58(8):489-94. PubMed ID: 7924316
    [No Abstract]   [Full Text] [Related]  

  • 80. Antibiotic use before chlamydia and gonorrhea genital and extragenital screening in the sexually transmitted infection clinical setting.
    Dukers-Muijrers NH; van Liere GA; Wolffs PF; Den Heijer C; Werner MI; Hoebe CJ
    Antimicrob Agents Chemother; 2015 Jan; 59(1):121-8. PubMed ID: 25313220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.